Blar i Bergen Open Research Archive på forfatter "Karlsson, Pär"

Viser treff 1-3 av 3

    • Atomoxetine in Early Pregnancy and the Prevalence of Major Congenital Malformations: A Multinational Study 

      Bröms, Gabriella; Hernandez-Diaz, Sonia; Huybrechts, Krista F.; Bateman, Brian T.; Kristiansen, Eskild Bendix; Einarsdóttir, Kristjana; Engeland, Anders; Furu, Kari; Gissler, Mika; Karlsson, Pär; Klungsøyr, Kari; Lahesmaa-Korpinen, Anna-Maria; Mogun, Helen; Nørgaard, Mette; Reutfors, Johan; Sørensen, Henrik Toft; Zoega, Helga; Kieler, Helle (Journal article; Peer reviewed, 2023)
      Objective: Most research on safety of attention-deficit/ hyperactivity disorder (ADHD) medications during pregnancy concerns central nervous system stimulants, while little is known about the safety of atomoxetine, a primary ...

    • Prenatal exposure to pregabalin, birth outcomes and neurodevelopment - a population-based cohort study in four Nordic countries 

      Dudukina, Elena; Szépligeti, Szimonetta Komjáthiné; Karlsson, Pär; Asomaning, Kofi; Daltveit, Anne Kjersti Nesje; Hakkarainen, Katja; Hoti, Fabian; Kieler, Helle; Lunde, Astrid; Odsbu, Ingvild; Rantanen, Matti; Reutfors, Johan; Saarelainen, Laura; Ehrenstein, Vera; Toft, Gunnar (Journal article; Peer reviewed, 2023)
      Introduction: Pregabalin is an antiepileptic drug frequently prescribed to pregnant women. Risks of adverse birth and postnatal neurodevelopmental outcomes following prenatal exposure to pregabalin are uncertain. Objective: ...

    • Use of sildenafil and other phosphodiesterase type 5 inhibitors among pregnant women in Scandinavia 

      Cesta, Carolyn E.; Segovia Chacón, Silvia; Engeland, Anders; Broe, Anne; Damkier, Per; Furu, Kari; Kieler, Helle; Karlsson, Pär (Journal article; Peer reviewed, 2021)
      Introduction For phosphodiesterase type 5 (PDE5) inhibitors, such as sildenafil, the only approved indication in women is for pulmonary arterial hypertension. These drugs are increasingly being proposed and tested for ...